Tilray Stock Gains Ahead of Next Week’s Earnings Call
Tilray stock is in the green today with Tilray Inc (NASDAQ:TLRY) set to report its third-quarter earnings at the close of trading next Tuesday, November 12. Can those earnings drive further growth for the battered ... [Read]
Tilray Stock Soars on Cannabis Trial in Peripheral Neuropathy
Tilray stock is the biggest gainer in the cannabis sector after Tilray (NASDAQ:TLRY) said that it has imported its supply of medical cannabis into the US to support a first-ever clinical trial. One Step Ahead ... [Read]
Tilray Stock Slumps Despite Merger Pact with a Key Shareholder
Tilray stock is moving lower despite the news that Tilray (NASDAQ:TLRY) inked a merger agreement with top stockholder Privateer Holdings. Important News for Shareholders The past few months have not been particularly great for most ... [Read]
Thinking About Cannabis Microdosing? Everything You Need to Know
Cannabis is more accepted today. But that doesn't mean consumers are not mindful of how it works, and how to use it. There are several different ways to consume cannabis, and not everyone is a ... [Read]
Tilray Stock Drops As Biggest Bull Cuts Price Target By 60%
Tilray Inc's (NASDAQ:TLRY) biggest bull has slashed her price target for the company by 60%, sending Tilray stock 2.7% into the red. Tilray Stock: Still A Good Opportunity? Vivien Azer of Cowen & Co. cut ... [Read]
Tilray Stock Dips As Company Announces FOUR20 Acquisition
Tilray (NASDAQ:TLRY) has today announced a $110 million CAD acquisition of Alberta pot retailer FOUR20, but Tilray stock is muted on the announcement. Tilray Stock Down During Thursday's Trading FOUR20, a Calgary-based cannabis retailer, currently ... [Read]
POTN Stock Down 2%: Preparing to Enter US Health and Beauty Market
POTN stock is trading in the red Thursday despite PotNetwork Holdings (OTC:POTN) releasing a mid-year letter to shareholders, which featured several highlights. In case you missed it, here's what the letter from CEO Kevin Hagen ... [Read]
Curaleaf Stock Soars 12% After Early Sell-Off Following Q2 Results
Curaleaf stock is witnessing heavy buying activities after early losses on Wednesday following Curaleaf Holdings (CSE:CURA) (OTCQX:CURLF) reporting lower than the estimated second-quarter results, but projecting over $1 billion of revenue in 2020. Poor Quarter ... [Read]
Delta 9 Stock Soars on Record Q2 Results and TSX Listing
Delta 9 Cannabis Inc (TSXV:DN) (OTCQX:VRNDF) posted record Q2 earnings yesterday ahead of being listed on the TSX. Delta 9 stock is up 10% as a result. Eyewatering Gains The company posted eyewatering gains in its ... [Read]
CRON Stock Extends Fall: Good or Bad Opportunity?
Cronos Group (TSX:CRON) (NASDAQ:CRON) is among the most valuable companies in the marijuana industry with a valuation of $4 billion, but recently the CRON stock had a bit of a rough ride. It went below ... [Read]